Form 8-K - Current report:
SEC Accession No. 0001193125-25-018840
Filing Date
2025-02-03
Accepted
2025-02-03 06:30:51
Documents
16
Period of Report
2025-02-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d843684d8k.htm   iXBRL 8-K 35120
2 EX-10.1 d843684dex101.htm EX-10.1 181029
3 EX-10.2 d843684dex102.htm EX-10.2 126310
4 EX-99.1 d843684dex991.htm EX-99.1 10185
  Complete submission text file 0001193125-25-018840.txt   566286

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tecx-20250203.xsd EX-101.SCH 2859
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tecx-20250203_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tecx-20250203_pre.xml EX-101.PRE 11267
18 EXTRACTED XBRL INSTANCE DOCUMENT d843684d8k_htm.xml XML 3639
Mailing Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472 (339) 666-3320
Tectonic Therapeutic, Inc. (Filer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 25580524
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)